Abstract

Sirtuins (SIRT) are NAD+-dependent histone deacetylases that play an important role in the functioning of the human body. They participate in numerous processes taking place in cells, including in the post-translational modification of proteins, silencing gene transcription, inducing repair processes, as well as in the regulation of metabolic processes. Sirtuins have also been shown to play an important role in reducing the level of reactive oxygen species as well as in stimulating cell growth, aging and death. Such a wide range of processes, which are affected by sirtuins, have recently made sirtuins the object of many studies aimed at a detailed understanding of the mechanisms of their action and the role they play. The aim of our study was to collect and systematize information on sirtuins, mainly from the last 10 years, both regarding the human body and based on the results of research on animal models or cell lines. The article discusses the structure, function and biological role of sirtuins in cellular processes.

References

• 1. Bannister A.J., Kouzarides T.: Regulation of chromatin by histonemodifications. Cell Res., 2011; 21: 381–395
  Google Scholar
• 2. Barber M.F., Michishita-Kioi E., Xi Y., Tasselli L., Kioi M., MoqtaderiZ., Tennen R.I., Paredes S., Young N.L., Chen K., Struhl K.,Garcia B.A., Gozani O., Li W., Chua K.F.: SIRT7 links H3K18 deacetylationto maintenance of oncogenic transformation. Nature,2012; 487: 114–118
  Google Scholar
• 3. Bordone L., Motta M.C., Picard F., Robinson A., Jhala U.S., ApfeldJ., McDonagh T., Lemieux M., McBurney M., Szilvasi A., Easlon E.J.,Lin S.J., Guarente L.: Sirt1 regulates insulin secretion by repressingUCP2 in pancreatic β cells. PLoS Biol., 2006; 4: e31
  Google Scholar
• 4. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y.,Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L.,Jedrychowski M.P., Gygi S.P., Sinclair D.A. i wsp.: Stress-dependentregulation of FOXO transcription factors by the SIRT1 deacetylase.Science, 2004; 303: 2011–2015
  Google Scholar
• 5. Chen S., Seiler J., Santiago-Reichelt M., Felbel K., Grummt I.,Voit R.: Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7.Mol. Cell, 2013; 52: 303–313
  Google Scholar
• 6. Cheng Y., Ren X., Gowda A.S., Shan Y., Zhang L., Yuan Y.S., PatelR., Wu H., Huber-Keener K., Yang J.W., Liu D., Spratt T.E., Yang J.M.:Interaction of Sirt3 with OGG1 contributes to repair of mitochondrialDNA and protects from apoptotic cell death under oxidativestress. Cell Death Dis., 2013; 4: e731
  Google Scholar
• 7. Christovam A.C., Theodoro V., Mendonça F.A., Esquisatto M.A.,dos Santos G.M., do Amaral M.E.: Activators of SIRT1 in wound repair:An animal model study. Arch Dermatol Res., 2019; 311: 193–201
  Google Scholar
• 8. Cimen H., Han M.J., Yang Y., Tong Q., Koc H., Koc E.C.: Regulationof succinate dehydrogenase activity by SIRT3 in mammalianmitochondria. Biochemistry., 2010; 49: 304–311
  Google Scholar
• 9. Dominy J.E. Jr, Lee Y., Jedrychowski M.P., Chim H., Jurczak M.J.,Camporez J.P., Ruan H.B., Feldman J., Pierce K., Mostoslavsky R.,Denu J.M., Clish C.B., Yang X., Shulman G.I., Gygi S.P. i wsp.: The deacetylaseSirt6 activates the acetyltransferase GCN5 and suppresseshepatic gluconeogenesis. Mol. Cell, 2012; 48: 900–913
  Google Scholar
• 10. Dryden S.C., Nahhas F.A., Nowak J.E., Goustin A.S., TainskyM.A.: Role for human SIRT2 NAD-dependent deacetylase activityin control of mitotic exit in the cell cycle. Mol. Cell. Biol., 2003;23: 3173–3185
  Google Scholar
• 11. Du J., Zhou Y., Su X., Yu J.J., Khan S., Jiang H., Kim J., Woo J.,Kim, J.H., Choi B.H., He B., Chen W., Zhang S., Cerione R.A., AuwerxJ. i wsp.: Sirt5 is a NAD-dependent protein lysine demalonylase anddesuccinylase. Science, 2011; 334: 806–809
  Google Scholar
• 12. Eckschlager T., Plch J., Stiborova M., Hrabeta J.: Histone deacetylaseinhibitors as anticancer drugs. Int. J. Mol. Sci., 2017; 18: 1414
  Google Scholar
• 13. Espenshade P.J.: SREBPs: Sterol-regulated transcription factors.J. Cell Sci., 2006; 119: 973–976
  Google Scholar
• 14. Fataftah N., Mohr C., Hajirezaei M.R., von Wirén N., HumbeckK.: Changes in nitrogen availability lead to a reprogramming ofpyruvate metabolism. BMC Plant Biol., 2018; 18: 77
  Google Scholar
• 15. Feldman J.L., Dittenhafer-Reed K.E., Denu J.M.: Sirtuin catalysisand regulation. J. Biol. Chem., 2012; 287: 42419–42427
  Google Scholar
• 16. Finley L.W., Haas W., Desquiret-Dumas V., Wallace D.C., ProcaccioV., Gygi S.P., Haigis M.C.: Succinate dehydrogenase is a directtarget of sirtuin 3 deacetylase activity. PLoS One, 2011; 6: e23295
  Google Scholar
• 17. Flick F., Lüscher B.: Regulation of sirtuin function by posttranslationalmodifications. Front. Pharmacol., 2012; 3: 29
  Google Scholar
• 18. Frye R.A.: Phylogenetic classification of prokaryotic and eukaryoticSir2-like proteins. Biochem. Biophys. Res. Commun., 2000;273: 793–798
  Google Scholar
• 19. Gao D., Wang H., Xu Y., Zheng D., Zhang Q., Li W.: Protectiveeffect of astaxanthin against contrast-induced acute kidney injuryvia SIRT1-p53 pathway in rats. Int. Urol. Nephrol., 2019; 51: 351–358
  Google Scholar
• 20. GeneCards.: https://www.genecards.org (15.06.2020)
  Google Scholar
• 21. Greiss S., Gartner A.: Sirtuin/Sir2 phylogeny, evolutionaryconsiderations and structural conservation. Mol. Cells, 2009; 28:407–415
  Google Scholar
• 22. Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K., ChristodoulouD.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., KarowM., Blander G., Wolberger C., Prolla T.A., Weindruch R., Alt F.W.,Guarente L.: SIRT4 inhibits glutamate dehydrogenase and opposesthe effects of calorie restriction in pancreatic β cells. Cell., 2006;126: 941–954
  Google Scholar
• 23. Hallows W.C., Yu W., Denu J.M.: Regulation of glycolytic enzymephosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation.J. Biol. Chem., 2012; 287: 3850–3858
  Google Scholar
• 24. Hikosaka K., Yaku K., Okabe K., Nakagawa T.: Implicationsof NAD metabolism in pathophysiology and therapeuticsfor neurodegenerative diseases. Nutr. Neurosci., 2019; DOI:10.1080/1028415X.2019.1637504
  Google Scholar
• 25. Horton J.D., Goldstein J.L., Brown M.S.: SREBPs: Activators ofthe complete program of cholesterol and fatty acid synthesis inthe liver. J. Clin. Invest., 2002; 109: 1125–1131
  Google Scholar
• 26. Houtkooper R.H., Pirinen E., Auwerx J:. Sirtuins as regulatorsof metabolism and healthspan. Nat. Rev. Mol. Cell Biol., 2012; 13:225–238
  Google Scholar
• 27. Hubbi M.E., Hu H., Kshitiz, Gilkes D.M., Semenza G.L.: Sirtuin-7inhibits the activity of hypoxia-inducible factors. J. Biol. Chem.,2013; 288: 20768–20775
  Google Scholar
• 28. Jacobs K.M., Pennington J.D., Bisht K.S., Aykin-Burns N., KimH.S., Mishra M., Sun L., Nguyen P., Ahn B.H., Leclerc J., Deng C.X.,Spitz D.R., Gius D.: SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent geneexpression. Int. J. Biol. Sci., 2008; 4: 291–299
  Google Scholar
• 29. Jeong J., Juhn K., Lee H., Kim S.H., Min B.H., Lee K.M., Cho M.H.,Park G.H., Lee K.H.: SIRT1 promotes DNA repair activity and deacetylationof Ku70. Exp. Mol. Med., 2007; 39: 8–13
  Google Scholar
• 30. Jęśko H., Strosznajder R.P.: Sirtuins and their interactions withtranscription factors and poly(ADP-ribose) polymerases. Folia Neuropathol.,2016; 54: 212–233
  Google Scholar
• 31. Jiang W., Wang S., Xiao M., Lin Y., Zhou L., Lei Q., Xiong Y., GuanK.L., Zhao S.: Acetylation regulates gluconeogenesis by promotingPEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. MolCell., 2011; 43: 33–44
  Google Scholar
• 32. Jing E., Gesta S., Kahn C.R.: SIRT2 regulates adipocyte differentiationthrough FoxO1 acetylation/deacetylation. Cell Metab.,2007; 6: 105–114
  Google Scholar
• 33. Jing H., Lin H.: Sirtuins in epigenetic regulation. Chem Rev.,2015; 115: 2350–2375
  Google Scholar
• 34. Johnson C.A.: Chromatin modification and disease. J. Med.Genet., 2000; 37: 905–915
  Google Scholar
• 35. Kahl G.: The dictionary of genomics, transcriptomics and proteomics.Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim 2015; Volume 1 A-D: 2156
  Google Scholar
• 36. Kaidi A., Weinert B.T., Choudhary C., Jackson S.P.: Human SIRT6promotes DNA end resection through CtIP deacetylation. Science,2010; 329: 1348–1353
  Google Scholar
• 37. Karim M.F., Yoshizawa T., Sobuz S.U., Sato Y., Yamagata K.:Sirtuin 7-dependent deacetylation of DDB1 regulates the expressionof nuclear receptor TR4. Biochem. Biophys. Res. Commun.,2017; 490: 423–428
  Google Scholar
• 38. Kouzarides T.: Chromatin modifications and their function.Cell., 2007; 128: 693–705
  Google Scholar
• 39. Kozako T., Suzuki T., Yoshimitsu M., Arima N., Honda S., SoedaS.: Anticancer agents targeted to sirtuins. Molecules, 2014; 19:20295–20313
  Google Scholar
• 40. Kupis W., Pałyga J., Tomal E., Niewiadomska E.: The role of sirtuinsin cellular homeostasis. J. Physiol. Biochem., 2016; 72: 371–380
  Google Scholar
• 41. Kyrylenko S., Kyrylenko O., Suuronen T., Salminen A.: Differentialregulation of the Sir2 histone deacetylase gene familyby inhibitors of class I and II histone deacetylases. Cell. Mol. LifeSci., 2003; 60: 1990–1997
  Google Scholar
• 42. Landry J., Sutton A., Tafrov S.T., Heller R.C., Stebbins J., PillusL., Sternglanz R.: The silencing protein SIR2 and its homologs areNAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. USA,2000; 97: 5807–5811
  Google Scholar
• 43. Langley E., Pearson M., Faretta M., Bauer U.M., Frye RA., MinucciS., Pelicci P.G., Kouzarides T.: Human SIR2 deacetylates p53and antagonizes PML/p53-induced cellular senescence. EMBO J.,2002; 21: 2383–2396
  Google Scholar
• 44. Laurent G., de Boer V.C., Finley L.W., Sweeney M., Lu H., SchugT.T., Cen Y., Jeong S.M., Li X., Sauve A.A., Haigis M.C.: SIRT4 repressesperoxisome proliferator-activated receptor α activity tosuppress hepatic fat oxidation. Mol. Cell. Biol., 2013; 33: 4552–4561
  Google Scholar
• 45. Laurent G., German N.J., Saha A.K., de Boer V.C., Davies M.,Koves T.R., Dephoure N., Fischer F., Boanca G., Vaitheesvaran B.,Lovitch S.B., Sharpe A.H., Kurland I.J., Steegborn C., Gygi S.P. iwsp: SIRT4 coordinates the balance between lipid synthesis andcatabolism by repressing malonyl-CoA decarboxylase. Mol. Cell.,2013; 50: 686–698
  Google Scholar
• 46. Li L., Shi L., Yang S., Yan R., Zhang D., Yang J., He L., Li W., Yi X.,Sun L., Liang J., Cheng Z., Shi L., Shang Y., Yu W.: SIRT7 is a histonedesuccinylase that functionally links to chromatin compaction andgenome stability. Nat. Commun., 2016; 7: 12235
  Google Scholar
• 47. Li W., Zhang B., Tang J., Cao Q., Wu Y., Wu C., Guo J., Ling E.A.,Liang F.: Sirtuin 2, a mammalian homolog of yeast silent informationregulator-2 longevity regulator, is an oligodendroglial proteinthat decelerates cell differentiation through deacetylatingα-tubulin. J. Neurosci., 2007; 27: 2606–2616
  Google Scholar
• 48. Lipska K., Filip A.A., Gumieniczek A.: Postępy w badaniachnad inhibitorami deacetylaz histonów jako lekami przeciwnowotworowymi.Postępy Hig. Med. Dośw., 2018; 72: 1018–1031
  Google Scholar
• 49. Liszt G., Ford E., Kurtev M., Guarente L.: Mouse Sir2 homologSIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem., 2005;280: 21313–21320
  Google Scholar
• 50. Lombard D.B., Alt F.W., Cheng H.L., Bunkenborg J., Streeper R.S.,Mostoslavsky R., Kim J., Yancopoulos G., Valenzuela D., MurphyA., Yang Y., Chen Y., Hirschey M.D., Bronson R.T., Haigis M. i wsp.:Mammalian Sir2 homolog SIRT3 regulates global mitochondriallysine acetylation. Mol. Cell. Biol., 2007; 27: 8807–8814
  Google Scholar
• 51. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., GuarenteL., Gu W.: Negative control of p53 by Sir2α promotes cell survivalunder stress. Cell., 2001; 107: 137–148
  Google Scholar
• 52. Luo K., Huang W., Tang S.: Sirt3 enhances glioma cell viabilityby stabilizing Ku70-BAX interaction. Onco Targets Ther., 2018;11: 7559–7567
  Google Scholar
• 53. Mao Z., Hine C., Tian X., Van Meter M., Au M., Vaidya A., SeluanovA., Gorbunova V.: SIRT6 promotes DNA repair under stressby activating PARP1. Science, 2011; 332: 1443–1446
  Google Scholar
• 54. Mathias R.A., Greco T.M., Cristea I.M.: Identification of sirtuin4(SIRT4) protein interactions: Uncovering candidate acyl-modifiedmitochondrial substrates and enzymatic regulators. Methods Mol.Biol., 2016; 1436: 213–239
  Google Scholar
• 55. Mathias R.A., Greco T.M., Oberstein A., Budayeva H.G., ChakrabartiR., Rowland E.A., Kang Y., Shenk T., Cristea I.M.: Sirtuin 4 is alipoamidase regulating pyruvate dehydrogenase complex activity.Cell., 2014; 159: 1615–1625
  Google Scholar
• 56. Matsushita N., Yonashiro R., Ogata Y., Sugiura A., NagashimaS., Fukuda T., Inatome R., Yanagi S.: Distinct regulation of mitochondriallocalization and stability of two human Sirt5 isoforms.Genes Cells, 2011; 16: 190–202
  Google Scholar
• 57. Maxwell P.H., Pugh C.W., Ratcliffe P.J.: The pVHL-hIF-1 system.A key mediator of oxygen homeostasis. Adv. Exp. Med. Biol.,2001; 502: 365–376
  Google Scholar
• 58. McCord R.A., Michishita E., Hong T., Berber E., Boxer L.D., KusumotoR., Guan S., Shi X., Gozani O., Burlingame A.L., Bohr V.A.,Chua K.F.: SIRT6 stabilizes DNA-dependent protein kinase at chromatinfor DNA double-strand break repair. Aging, 2009; 1: 109–121
  Google Scholar
• 59. Mei Z., Zhang X., Yi J., Huang J., He J., Tao Y.: Sirtuins in metabolism,DNA repair and cancer. J. Exp. Clin. Cancer Res., 2016; 35: 182
  Google Scholar
• 60. Meijer A.J., Lamers W.H., Chamuleau R.A.: Nitrogen metabolismand ornithine cycle function. Physiol Rev., 1990; 70: 701–748
  Google Scholar
• 61. Michan S., Sinclair D.: Sirtuins in mammals: Insights into theirbiological function. Biochem. J., 2007; 404: 1–13
  Google Scholar
• 62. Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H.,Damian M., Cheung P., Kusumoto R., Kawahara T.L., Barrett J.C.,Chang H.Y., Bohr V.A., Ried T., Gozani O., Chua K.F.: SIRT6 is a histoneH3 lysine 9 deacetylase that modulates telomeric chromatin.Nature, 2008; 452: 492–496
  Google Scholar
• 63. Muth V., Nadaud S., Grummt I., Voit R.: Acetylation of TAFI68,a subunit of TIF-IB/SL1, activates RNA polymerase I transcription.EMBO J., 2001; 20: 1353–1362
  Google Scholar
• 64. Nakae J., Oki M., Cao Y.: The FoxO transcription factors andmetabolic regulation. FEBS Lett., 2008; 582: 54–67
  Google Scholar
• 65. Nakagawa T., Lomb D.J., Haigis M.C., Guarente L.: SIRT5 deacetylatescarbamoyl phosphate synthetase 1 and regulates the ureacycle. Cell, 2009; 137: 560–570
  Google Scholar
• 66. Nakamura Y., Ogura M., Ogura K., Tanaka D., Inagaki N.: SIRT5deacetylates and activates urate oxidase in liver mitochondria ofmice. FEBS Lett., 2012; 586: 4076–4081
  Google Scholar
• 67. Nishida Y., Rardin M.J., Carrico C., He W., Sahu A.K., Gut P., NajjarR., Fitch M., Hellerstein M., Gibson B.W., Verdin E.: SIRT5 regulatesboth cytosolic and mitochondrial protein malonylation withglycolysis as a major target. Mol. Cell., 2015; 59: 321–332
  Google Scholar
• 68. North B.J., Marshall B.L., Borra M.T., Denu J.M., Verdin E.: Thehuman Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.Mol. Cell, 2003; 11: 437–444
  Google Scholar
• 69. Obsil T., Obsilova V.: Structure/function relationships underlyingregulation of FOXO transcription factors. Oncogene, 2008;27: 2263–2275
  Google Scholar
• 70. Osborne T.F., Espenshade P.J.: Evolutionary conservation andadaptation in the mechanism that regulates SREBP action: What along, strange tRIP it’s been. Genes Dev., 2009; 23: 2578–2591
  Google Scholar
• 71. Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z.,Zhang Y., Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.: SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways.Mol. Cell, 2013; 50: 919–930
  Google Scholar
• 72. Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., ZhangY., He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D.,He T.C. i wsp.: The first identification of lysine malonylation substratesand its regulatory enzyme. Mol. Cell Proteomics, 2011; 10:M111.012658
  Google Scholar
• 73. Picard F., Kurtev M., Chung N., Topark-Ngarm A., SenawongT., Machado de Oliviera R., Leid M., McBurney M.W., Guarente L.:Sirt1 promotes fat mobilization in white adipocytes by repressingPPAR-γ. Nature, 2004; 429: 771–776
  Google Scholar
• 74. Polletta L., Vernucci E., Carnevale I., Arcangeli T., Rotili D.,Palmerio S., Steegborn C., Nowak T., Schutkowski M., PellegriniL., Sansone L., Villanova L., Runci A., Pucci B., Morgante E. i wsp.:SIRT5 regulation of ammonia-induced autophagy and mitophagy.Autophagy, 2015; 11: 253–270
  Google Scholar
• 75. Ponugoti B., Kim D.H., Xiao Z., Smith Z., Miao J., Zang M., WuS.Y., Chiang C.M., Veenstra T.D., Kemper J.K.: SIRT1 deacetylatesand inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.J. Biol. Chem., 2010; 285: 33959–33970
  Google Scholar
• 76. Ramsey K.M., Mills K.F., Satoh A., Imai S.I.: Age-associated lossof Sirt1-mediated enhancement of glucose-stimulated insulin secretionin beta cell-specific Sirt1-overexpressing (BESTO) mice.Aging Cell, 2008; 7: 78–88
  Google Scholar
• 77. Rangarajan P., Karthikeyan A., Lu J., Ling E.A., Dheen S.T.: Sirtuin 3 regulates Foxo3a-mediated antioxidant pathway in microglia.Neuroscience, 2015; 311: 398–414
  Google Scholar
• 78. Rardin M.J., He W., Nishida Y., Newman J.C., Carrico C., DanielsonS.R., Guo A., Gut P., Sahu A.K,. Li B., Uppala R., Fitch M.,Riiff T., Zhu L., Zhou J. i wsp.: SIRT5 regulates the mitochondriallysine succinylome and metabolic networks. Cell Metab., 2013;18: 920–933
  Google Scholar
• 79. Rodgers J.T., Lerin C., Gerhart-Hines Z., Puigserver P.: Metabolicadaptations through the PGC-1α and SIRT1 pathways. FEBSLett., 2008; 582: 46–53
  Google Scholar
• 80. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M.,Puigserver P.: Nutrient control of glucose homeostasis through acomplex of PGC-1α and SIRT1. Nature, 2005; 434: 113–118
  Google Scholar
• 81. Rodgers J.T., Puigserver P.: Fasting-dependent glucose and lipidmetabolic response through hepatic sirtuin 1. Proc. Natl. Acad.Sci. USA, 2007; 104: 12861–12866
  Google Scholar
• 82. Rorbach-Dolata A., Kubis A., Piwowar A.: Modyfikacje epigenetyczne– ważny mechanizm w zaburzeniach cukrzycy. PostępyHig. Med. Dośw., 2017; 71: 960–974
  Google Scholar
• 83. Ryu D., Jo Y.S., Lo Sasso G., Stein S., Zhang H., Perino A., LeeJ.U., Zeviani M., Romand R., Hottiger M.O., Schoonjans K., AuwerxJ.: A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrialfunction. Cell. Metab., 2014; 20: 856–869
  Google Scholar
• 84. Sanders B.D., Jackson B., Marmorstein R.: Structural basis forsirtuin function: What we know and what we don’t. Biochim. Biophys.Acta, 2010; 1804: 1604–1616
  Google Scholar
• 85. Scher M.B., Vaquero A., Reinberg D.: SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondriaupon cellular stress. Genes Dev., 2007; 21: 920–928
  Google Scholar
• 86. Schiedel M., Robaa D., Rumpf T., Sippl W., Jung M.: The currentstate of NAD+-dependent histone deacetylases (sirtuins) as noveltherapeutic targets. Med. Res. Rev., 2017; 37: 147–200
  Google Scholar
• 87. Schwer B., North B.J., Frye R.A., Ott M., Verdin E.: The humansilent information regulator (Sir)2 homologue hSIRT3 is a mitochondrialnicotinamide adenine dinucleotide-dependent deacetylase.J. Cell. Biol., 2002; 158: 647–657
  Google Scholar
• 88. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., WatsonD.G., Mansfield K.D., Pan Y., Simon M.C., Thompson C.B., Gottlieb E.:Succinate links TCA cycle dysfunction to oncogenesis by inhibitingHIF-α prolyl hydroxylase. Cancer Cell, 2005; 7: 77–85
  Google Scholar
• 89. Semenza G.L.: Regulation of oxygen homeostasis by hypoxiainduciblefactor 1. Physiology, 2009; 24: 97–106
  Google Scholar
• 90. Shin J., He M., Liu Y., Paredes S., Villanova L., Brown K., QiuX., Nabavi N., Mohrin M., Wojnoonski K. Li P., Cheng H.L., MurphyA.J., Valenzuela D.M., Luo H. i wsp.: SIRT7 represses Myc activityto suppress ER stress and prevent fatty liver disease. Cell Rep.,2013; 5: 654–665
  Google Scholar
• 91. Siedlecka K., Bogusławski W.: Sirtuiny – enzymydługowieczności? Gerontol. Pol., 2005; 13: 147–152
  Google Scholar
• 92. Snyder C.A., Goodson M.L., Schroeder A.C., Privalsky M.L.:Regulation of corepressor alternative mRNA splicing by hormonaland metabolic signaling. Mol. Cell. Endocrinol., 2015; 413: 228–235
  Google Scholar
• 93. Sundaresan N.R., Samant S.A., Pillai V.B., Rajamohan S.B., GuptaM.P.: SIRT3 is a stress responsive deacetylase in cardiomyocytesthat protects cells from stress-mediated cell death by deacetylationof Ku70. Mol. Cell. Biol., 2008; 28: 6384–6401
  Google Scholar
• 94. Tan M., Peng C., Anderson K.A., Chhoy P., Xie Z., Dai L., ParkJ., Chen Y., Huang H., Zhang Y., Ro J., Wagner G.R., Green M.F.,Madsen A.S., Schmiesing J. i wsp.: Lysine glutarylation is a proteinposttranslational modification regulated by SIRT5. Cell. Metab.,2014; 19: 605–617
  Google Scholar
• 95. Tavares C.D., Sharabi K., Dominy J.E., Lee Y., Isasa M., OrozcoJ.M., Jedrychowski M.P., Kamenecka T.M., Griffin P.R., Gygi S.P.,Puigserver P.: The methionine transamination pathway controlshepatic glucose metabolism through regulation of the GCN5 acetyltransferaseand the PGC-1α transcriptional coactivator. J. Biol.Chem., 2016; 291: 10635–10645
  Google Scholar
• 96. Tennen R.I., Bua D.J., Wright W.E., Chua K.F.: SIRT6 is requiredfor maintenance of telomere position effect in human cells. Nat.Commun., 2011; 2: 433
  Google Scholar
• 97. Tsai Y.C., Greco T.M., Cristea I.M.: Sirtuin7 plays a role in ribosomebiogenesis and protein synthesis. Mol. Cell. Proteomics,2014; 13: 73–83
  Google Scholar
• 98. van der Horst A., Tertoolen L.G., de Vries-Smits L.M., Frye R.A.,Medema R.H., Burgering B.M.: FOXO4 is acetylated upon peroxidestress and deacetylated by the longevity protein hSir2(SIRT1). J.Biol. Chem., 2004; 279: 28873–28879
  Google Scholar
• 99. Vaquero A., Scher M., Lee D., Erdjument-Bromage H., TempstP., Reinberg D.: Human SirT1 interacts with histone H1 and promotesformation of facultative heterochromatin. Mol. Cell., 2004;16: 93–105
  Google Scholar
• 100. Vaquero A., Scher M.B., Lee D.H., Sutton A., Cheng H.L., AltF.W., Serrano L., Sternglanz R., Reinberg D.: SirT2 is a histone deacetylasewith preference for histone H4 Lys 16 during mitosis.Genes Dev., 2006; 20: 1256–1261
  Google Scholar
• 101. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., PanditaT.K., Guarente L., Weinberg R.A.: hSIR2 (SIRT1) functions as anNAD-dependent p53 deacetylase. Cell, 2001; 107: 149–159
  Google Scholar
• 102. Walker A.K., Yang F., Jiang K., Ji J.Y., Watts J.L., PurushothamA,. Boss O., Hirsch M.L., Ribich S., Smith J.J., Israelian K., WestphalC.H., Rodgers J.T., Shioda T., Elson S.L. i wsp.: Conserved role ofSIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterolregulator SREBP. Genes Dev., 2010; 24: 1403–1417
  Google Scholar
• 103. Wang F., Chan C.H., Chen K., Guan X., Lin H.K., Tong Q.: Deacetylationof FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3ubiquitination and degradation. Oncogene, 2012; 31: 1546–1557
  Google Scholar
• 104. Wang F., Nguyen M., Qin F.X., Tong Q.: SIRT2 deacetylatesFOXO3a in response to oxidative stress and caloric restriction.Aging Cell, 2007; 6: 505–514
  Google Scholar
• 105. Wang F., Tong Q.: SIRT2 suppresses adipocyte differentiationby deacetylating FOXO1 and enhancing FOXO1’s repressive interactionwith PPARγ. Mol. Biol. Cell, 2009; 20: 801–808
  Google Scholar
• 106. Webb A.E., Brunet A.: FOXO transcription factors: Key regulatorsof cellular quality control. Trends Biochem. Sci., 2014; 39:159–169
  Google Scholar
• 107. Wiercińska M., Rosołowska-Huszcz D.: Naturalne i syntetycznemodulatory aktywności sirtuin. Kosmos, 2017; 66: 365–377
  Google Scholar
• 108. Yamamoto H., Schoonjans K., Auwerx J.: Sirtuin functions inhealth and disease. Mol. Endocrinol., 2007; 21: 1745–1755
  Google Scholar
• 109. Yang B., Zwaans B.M., Eckersdorff M., Lombard D.B.: Thesirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomicstability. Cell Cycle, 2009; 8: 2662–2663
  Google Scholar
• 110. Yang S.R., Wright J., Bauter M., Seweryniak K., Kode A., RahmanI.: Sirtuin regulates cigarette smoke-induced proinflammatorymediator release via RelA/p65 NF-κB in macrophages in vitro andin rat lungs in vivo: Implications for chronic inflammation and aging.Am. J. Physiol. Lung Cell Mol. Physiol., 2007; 292: L567–L576
  Google Scholar
• 111. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R.,Frye R.A., Mayo M.W.: Modulation of NF-κB-dependent transcriptionand cell survival by the SIRT1 deacetylase. EMBO J., 2004; 23:2369–2380
  Google Scholar
• 112. Zhang M., Pan Y., Dorfman R.G., Yin Y., Zhou Q., Huang S., LiuJ., Zhao S.: Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesisby inhibiting deacetylase SIRT2. Sci Rep., 2017; 7: 7
  Google Scholar
• 113. Zhang P.Y., Li G., Deng Z.J., Liu L.Y., Chen L., Tang J.Z., WangY.Q., Cao S.T., Fang Y.X., Wen F., Xu Y., Chen X., Shi K.Q., Li W.F., XieC. i wsp.: Dicer interacts with SIRT7 and regulates H3K18 deacetylationin response to DNA damaging agents. Nucleic Acids Res.,2016; 44: 3629–3642
  Google Scholar
• 114. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., ZhouL., Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F. i wsp.:Regulation of cellular metabolism by protein lysine acetylation.Science, 2010; 327: 1000–1004
  Google Scholar
• 115. Zhao T., Alam H.B., Liu B., Bronson R.T., Nikolian V.C., Wu E.,Chong W., Li Y.: Selective inhibition of SIRT2 improves outcomes ina lethal septic model. Curr. Mol. Med., 2015; 15: 634–641
  Google Scholar
• 116. Zhong L., Mostoslavsky R.: SIRT6: A master epigenetic gatekeeperof glucose metabolism. Transcription, 2010; 1: 17–21
  Google Scholar
• 117. Zhong L., D’Urso A., Toiber D., Sebastian C., Henry R.E., VadysirisackD.D., Guimaraes A., Marinelli B., Wikstrom J.D., Nir T., ClishC.B., Vaitheesvaran B., Iliopoulos O., Kurland I., Dor Y. i wsp.: Thehistone deacetylase Sirt6 regulates glucose homeostasis via Hif1α.Cell, 2010; 140: 280–293
  Google Scholar

Full text